Tetracycline Hydrochloride/Metronidazole/Bismuth Potassium Citrate

盐酸四环素/甲硝唑/枸橼酸铋钾

Report date: 2026/03/04 20:01:44

Base Information

Drug NameTetracycline Hydrochloride/Metronidazole/Bismuth Potassium Citrate
Drug Alias Namepotassium dicitrato bismuthate/tetracycline /metronidazole盐酸四环素/枸橼酸铋钾/甲硝唑Bismuth/metronidazole/tetracycline枸橼酸铋钾/甲硝唑/盐酸四环素枸橼酸铋钾+甲硝唑+四环素 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionProtein biosynthesis inhibitors30S ribosomal subunit inhibitorsDNA synthesis inhibitors +[4] 
Targets30S ribosomal subunitCytochrome P450 51
Therapy Area/IndicationsHelicobacter pylori infectionStomach UlcerDuodenal Ulcer
Global Approved IndicationsHelicobacter pylori infectionDuodenal Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/09/28
Country/TerritoryUnited StatesMainland China
CombinationsYes Tetracycline HydrochlorideMetronidazoleBismuth Potassium Citrate
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAdare Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Juvise PharmaceuticalsShandong Bestcomm Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionStomach UlcerDuodenal Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeA02BD08
Related LinksWikipediaKEGG